CLINICAL_TRIALS
withdrawal
· 2016-03-14
Clinical Trial Update: Effectiveness of ACS in Extreme Preemies [Phase 3]
Summary
A Phase 3 trial evaluating antenatal corticosteroids for extreme preemies has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pediatrix | Conditions: Preterm Labor, Premature Birth | Phase 3 | Status: WITHDRAWN